70 related articles for article (PubMed ID: 12445669)
1. Quality assurance in screening strategies.
Miller AB
Virus Res; 2002 Nov; 89(2):295-9. PubMed ID: 12445669
[TBL] [Abstract][Full Text] [Related]
2. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
Cubie HA; Moore C; Waller M; Moss S;
J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
[TBL] [Abstract][Full Text] [Related]
3. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
4. Screening for cervical cancer.
Wright TC; Goldie SJ; Cain JM; Howett MK
Science; 2000 Dec; 290(5497):1651. PubMed ID: 11186376
[No Abstract] [Full Text] [Related]
5. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.
Goldie SJ; Freedberg KA; Weinstein MC; Wright TC; Kuntz KM
Am J Med; 2001 Aug; 111(2):140-9. PubMed ID: 11498068
[TBL] [Abstract][Full Text] [Related]
6. Role of HPV testing in clinical practice.
Cuzick J
Virus Res; 2002 Nov; 89(2):263-9. PubMed ID: 12445665
[No Abstract] [Full Text] [Related]
7. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
Stoler MH
J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
[TBL] [Abstract][Full Text] [Related]
8. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
9. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and cervical disease in adolescents.
Guido R
Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
[TBL] [Abstract][Full Text] [Related]
11. Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing.
Cuschieri K; Schuurman R; Coughlan S
Cytopathology; 2019 May; 30(3):273-280. PubMed ID: 30657615
[TBL] [Abstract][Full Text] [Related]
12. New tests for cervical cancer screening.
Nuovo J; Melnikow J; Howell LP
Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
14. Adding a test for human papillomavirus DNA to cervical-cancer screening.
Wright TC; Schiffman M
N Engl J Med; 2003 Feb; 348(6):489-90. PubMed ID: 12571255
[No Abstract] [Full Text] [Related]
15. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
16. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.
Franco EL
J Natl Cancer Inst Monogr; 2003; (31):89-96. PubMed ID: 12807951
[TBL] [Abstract][Full Text] [Related]
17. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
[TBL] [Abstract][Full Text] [Related]
18. Primary human papillomavirus testing in organized cervical screening.
Dillner J
Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
[TBL] [Abstract][Full Text] [Related]
19. Update on cervical cancer screening. Current diagnostic and evidence-based management protocols.
Ball C; Madden JE
Postgrad Med; 2003 Feb; 113(2):59-64, 70. PubMed ID: 12611115
[TBL] [Abstract][Full Text] [Related]
20. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.
Zuna RE; Moore W; Dunn ST
Mod Pathol; 2001 Mar; 14(3):147-51. PubMed ID: 11266518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
